PO.BCS01.02 · 生物信息与计算
利用DeepSAP发现前列腺癌中新的剪接位点
Uncovering novel splice junctions in prostate cancer using DeepSAP
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
从RNA-seq准确表征可变剪接和基因融合事件对理解癌症生物学至关重要,然而,由于复杂的剪接位点结构、多重比对读段导致的模糊读段映射,以及混淆标准分析流程的嵌合转录本等因素,这一任务本质上仍具有挑战性。我们提出DeepSAP,一种剪接感知的RNA-seq比对工具,它将GSNAP中实现的转录组引导基因组比对(Transcriptome-Guided Genomic Alignment,TGGA)与先进的基于Transformer的剪接位点评分(Transformer-based Splice Junction Scoring,TSJS)相结合,以克服这些挑战,在检测真实剪接事件时实现更高的灵敏度和特异度。DeepSAP利用一个经过微调的DNABERT模型,该模型在从多个物种精选的剪接供体和受体位点序列上训练,使用剪接位点周围不同长度(90、150、200和400 bp)的序列窗口。在评估的不同微调模型中,DNABERT MS150在区分真实剪接位点方面表现出优越性能,并被直接整合到DeepSAP工作流程中,以重新评分并优先排序由GSNAP TGGA识别的候选剪接位点,有效地结合了局部DNA背景中序列驱动的合理性并得到RNA-seq读段的有力支持。为了在临床相关环境中评估DeepSAP,我们将其应用于一个前列腺癌RNA-seq队列(PRJNA579899,苏黎世大学医院)。在该队列中,DeepSAP一致地识别出大量当前基因注释中不存在、且常被现有最先进RNA-seq比对工具遗漏或仅微弱检测到的高置信度新剪接位点。值得注意的是,在FOXA1中,DeepSAP解析出一个具有双腺嘌呤替换的新供体位点,形成了此前未注释的外显子-内含子边界。该位点显示出连贯的读段覆盖以及Transformer衍生的高供体和受体概率,而其他比对工具在同一基因座未能产生一致的剪接位点。在ERG癌基因中也观察到类似模式,DeepSAP恢复了一个未被其他比对工具捕获的额外复杂、未注释剪接位点。这些结果凸显了DeepSAP在肿瘤RNA-seq数据中恢复复杂、此前未描述剪接位点的能力,并表明将GSNAP TGGA与TSJS相结合可显著提高比对灵敏度和特异度,从而改善对癌症RNA-seq样本中候选致癌剪接事件的检测。
查看英文原文 English abstract
Accurate characterization of alternative splicing and gene fusion events from RNA-seq is crucial for understanding cancer biology, however, this task remains inherently challenging due to factors such as complex splice junction architecture, ambiguous read mapping caused by multi-mapped reads, and the presence of chimeric transcripts that confound standard analysis pipelines. We present DeepSAP, a splice-aware RNA-seq aligner that integrates Transcriptome-Guided Genomic Alignment (TGGA) as implemented in GSNAP with advanced Transformer-based Splice Junction Scoring (TSJS) to overcome these challenges and achieve greater sensitivity and specificity in detecting true splicing events. DeepSAP leverages a fine-tuned DNABERT model, trained on curated splice donor and acceptor site sequences drawn from multiple species, utilizing sequence windows of varying lengths (90, 150, 200, and 400 bp) around the splice junctions. Among the different fine-tuned models evaluated, DNABERT MS150 demonstrated superior performance in distinguishing true splice sites, and is directly integrated into the DeepSAP workflow to re-score and prioritize candidate splice junctions identified by GSNAP TGGA, effectively combining both sequence-driven plausibility in local DNA context and strongly supported by RNA-seq reads. To evaluate DeepSAP in a clinically relevant setting, we applied it to a prostate cancer RNA-seq cohort (PRJNA579899, University Hospital Zurich). In this cohort, DeepSAP consistently identifies numerous high-confidence, novel splice junctions absent from current gene annotations and frequently missed or only weakly detected by current state of the art RNA-seq aligners. Notably, in FOXA1, DeepSAP resolves a novel donor site with a double-adenine substitution that creates a previously unannotated exon-intron boundary. This junction shows coherent read coverage and high transformer derived donor and acceptor probabilities, whereas alternative aligners fail to produce a consistent splice junction at the same locus. A similar pattern is observed in the ERG oncogene, where DeepSAP recovers an additional complex, unannotated splice junction that is not captured by other aligners. The results highlight DeepSAP's ability to recover complex, previously undescribed splice junctions in tumor RNA-seq data and demonstrate that coupling GSNAP TGGA with TSJS substantially improves alignment sensitivity and specificity, enabling improved detection of candidate oncogenic splice events in cancer RNA-seq samples.
利益披露 Disclosure
P. Vats, None..
F. Berakdar, None..
T. D. Wu, None..
T. Zhu, None..
M. Samadi, None.